Dr. Chapman's research focuses on mechanisms of cyst formation in autosomal dominant polycystic kidney disease. She has been integrally involved in the development of novel imaging biomarkers for this disease. Dr. Chapman also studies personalized or precision medicine and the role that genetic background plays in predicting antihypertensive responses to blood pressure medications used to treat hypertension. Dr. Chapman's early investigations centered on the renal and systemic changes to blood circulation that occur during preeclampsia. She has received continuous funding for her work from the National Institutes of Health (NIH) over the past 18 years.
Nephrology